Recep Yagiz
He completed his medical education at İstanbul University Cerrahpaşa Faculty of Medicine, graduating in 1991. Doctorate/Residency: His specialty training (Doctora/Residency) was in the Department of Otorhinolaryngology at Trakya University Faculty of Medicine, which he completed in 1999. He was appointed Assistant Professor Doctor in the ENT Department in 2001. He achieved the rank of Associate Professor Doctor in 2006. He became a Professor Doctor in 2011. Chief of Department: He has served as the Head of the Department of Otorhinolaryngology at the Faculty of Medicine since July 3, 2023.
Otology and Hearing Studies: A significant portion of his research involves the ear, hearing, and the potential effects of medical treatments:
Ototoxicity: Investigating the protective and damaging effects of various substances on the ear, including:The protective effect of substances like ascorbic acid (Vitamin C) and magnesium against ototoxicity caused by drugs like cisplatin (a chemotherapy drug) or noise-induced hearing loss. Evaluating the possible ototoxic effects of topical applications like rifamycin, povidone-iodine, and antibiotics like azithromycin and clarithromycin, using electrophysiological tests such as Auditory Brainstem Responses (ABR) and Otoacoustic Emissions (OAE).
Hearing Disorders: Studies on the evaluation of hearing, including: Assessing hearing in children with conditions like Autism Spectrum Disorder using OAE and ABR. Research into the effects of middle ear conditions (like effusion and chronic suppurative otitis media) on hearing and the use of treatments like nebulized surfactant for otitis media with effusion.
Ear Surgery: Research related to surgical techniques, such as: Comparing the use of scapha vs. tragus cartilage grafts in cartilage tympanoplasty (eardrum repair) for morbidity and cosmetic results. Studies on the Combined Heermann and Tos (CHAT) technique in cholesteatoma surgery.
Session
This session explores the cutting-edge frontier of inner ear therapeutics. We will cover groundbreaking innovations, including gene therapy for hereditary deafness, regenerative medicine for hair cell restoration, and novel drug delivery systems for treating hearing and balance disorders.
Outcome Objectives Participants will be able to:
Describe emerging gene and cell-based strategies for hearing restoration.
Evaluate the potential of next-generation cochlear and vestibular implants.
Identify new pharmacological targets and delivery methods for the inner ear.
Background Sensorineural hearing loss and vestibular disorders have long been considered irreversible. Advances in molecular biology and bioengineering are now challenging this paradigm, creating unprecedented opportunities for biological repair and functional restoration of the inner ear.